1. Home
  2. BOLT vs POLA Comparison

BOLT vs POLA Comparison

Compare BOLT & POLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLT
  • POLA
  • Stock Information
  • Founded
  • BOLT 2015
  • POLA 1979
  • Country
  • BOLT United States
  • POLA United States
  • Employees
  • BOLT N/A
  • POLA N/A
  • Industry
  • BOLT Biotechnology: Pharmaceutical Preparations
  • POLA Industrial Machinery/Components
  • Sector
  • BOLT Health Care
  • POLA Miscellaneous
  • Exchange
  • BOLT Nasdaq
  • POLA Nasdaq
  • Market Cap
  • BOLT 11.5M
  • POLA 11.5M
  • IPO Year
  • BOLT 2021
  • POLA 2016
  • Fundamental
  • Price
  • BOLT $4.75
  • POLA $3.60
  • Analyst Decision
  • BOLT Buy
  • POLA
  • Analyst Count
  • BOLT 4
  • POLA 0
  • Target Price
  • BOLT $34.00
  • POLA N/A
  • AVG Volume (30 Days)
  • BOLT 20.9K
  • POLA 882.9K
  • Earning Date
  • BOLT 11-14-2025
  • POLA 11-14-2025
  • Dividend Yield
  • BOLT N/A
  • POLA N/A
  • EPS Growth
  • BOLT N/A
  • POLA N/A
  • EPS
  • BOLT N/A
  • POLA N/A
  • Revenue
  • BOLT $4,167,000.00
  • POLA $11,967,000.00
  • Revenue This Year
  • BOLT N/A
  • POLA N/A
  • Revenue Next Year
  • BOLT N/A
  • POLA N/A
  • P/E Ratio
  • BOLT N/A
  • POLA N/A
  • Revenue Growth
  • BOLT N/A
  • POLA 0.14
  • 52 Week Low
  • BOLT $4.59
  • POLA $1.53
  • 52 Week High
  • BOLT $13.80
  • POLA $5.75
  • Technical
  • Relative Strength Index (RSI)
  • BOLT 35.12
  • POLA 46.91
  • Support Level
  • BOLT $5.65
  • POLA $3.48
  • Resistance Level
  • BOLT $5.93
  • POLA $4.25
  • Average True Range (ATR)
  • BOLT 0.35
  • POLA 0.48
  • MACD
  • BOLT -0.14
  • POLA -0.08
  • Stochastic Oscillator
  • BOLT 0.00
  • POLA 23.37

About BOLT Bolt Biotherapeutics Inc.

Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.

About POLA Polar Power Inc.

Polar Power Inc is engaged in designing, manufacturing, and selling DC power generators, renewable energy, and cooling systems for applications in the telecommunications market and, to a lesser extent, in other markets, including military, electric vehicle, marine, and industrial. The company's products include DC generators, backup DC generators, hybrid power systems, Li-Ion battery systems, Marine DC generators, and others. The company's geographical presence is in the United States, Canada, Australia and South Pacific Islands, Asia, Europe and Middle East, United Kingdom, Other North America, South Africa, and others.

Share on Social Networks: